Culturally Modified Diet for Type 2 Diabetes

Overseen by Minal Moharir, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Stanford University

No Placebo Group

Trial Summary

What is the purpose of this trial?

The investigators are hoping to determine whether tailoring the diet of someone with type 2 diabetes to their ethnic group while following American Diabetes Association guidelines can make a significant difference in their blood sugar controls. Participants will be required to wear a Continuous Glucose Monitor (CGM) for 1-month so that the investigators can compare blood sugar levels when participants are eating their routine diet vs. the culturally tailored diabetes diet.

Research Team

Minal Moharir, MD

Principal Investigator

Stanford University

Eligibility Criteria

This trial is for Asian Americans with type 2 diabetes who may also have hypertension. Participants will need to wear a Continuous Glucose Monitor (CGM) for one month and are willing to try a culturally modified diet.

Inclusion Criteria

Self-identification as Asian Indian or Filipino

I have been diagnosed with type 2 diabetes.

I can pick up meals from a specific place at Stanford.

Exclusion Criteria

Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat

Those who, in the opinion of the investigators, cannot reliably complete the study protocol.

I am currently taking insulin, GLP-1, and SGLT2 medications.

Treatment Details

Interventions

• NOURISH's Culturally Modified Meals (Behavioural Intervention)

Trial Overview The study aims to compare the effects of participants' self-selected diets versus specially tailored meals that align with their cultural preferences while adhering to American Diabetes Association guidelines on blood sugar control.

Participant Groups

Group I: Self Selected Diet to NOURISH Diet Experimental Treatment 2 Interventions

Participants in this arm will be consuming self-selected meals (baseline/control) first (During Week 2 of the intervention), followed by the NOURISH diet in the next week (Week 3). Participants will be required to fill out a food diary and questionnaires using the Tastermonital app.

Group II: NOURISH Diet to Self-Selected Diet Experimental Treatment 2 Interventions

Participants in this arm will be consuming the NOURISH diet first (During Week 2 of the intervention), followed by their self-selected diet (baseline/control) in the next week (Week 3). Participants will be required to fill out a food diary and questionnaires using the Tastermonital app.

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials

2,527

Recruited

17,430,000+

Dr. Richard A. Miller

Stanford University

Chief Executive Officer since 2023

Stanford University, MD

Dr. Robert Schott

Stanford University

Chief Medical Officer since 2021

University of Michigan, MD

Tastermonial Inc

Industry Sponsor

Trials

2

Recruited

60+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials

2,513

Recruited

4,366,000+

Dr. Griffin P. Rodgers

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Chief Executive Officer since 2007

MD, M.A.C.P.

Dr. Griffin P. Rodgers

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Chief Medical Officer since 2007

MD, M.A.C.P.